Pay in 4 interest-free payments of $5.18 Learn more
Ships within 48 hours · Estimated delivery Oct 14 - Oct 19
The ideal injection site depends on your age and the comfort level of the person administering the injection
The longest clinical trials extended to 24 weeks (approximately six months) of continuous AOD-9604 administration
Caution is advised in patients with Leber optic atrophy, a genetic disorder caused by chronic cyanide intoxication (such as from smoking, alcohol or some plants), against the use of cyano-B12 due to its cyanide moiety, whilst hydroxo-B12 is a cyanide antagonist and can therefore be used in these patients
The molecule was developed by Frank Ng's group at Monash University and Metabolic Pharmaceuticals in Australia during the 1990s and 2000s as a potential anti-obesity drug intended to isolate the lipolytic region of hGH without activating the growth hormone receptor or raising IGF-1.nnIn published preclinical work, the fragment has been shown to stimulate lipolysis, suppress lipogenesis, and modulate the beta-3 adrenergic receptor pathway in adipose tissue rather than acting through the classical hGH receptor
Some people notice improvements within a few weeks, while others may require several months of consistent treatment
Generally, the frequency differs from person to person and is decided by the doctor
US$ 25.57
US$ 21.67
US$ 24.83
US$ 28.99
US$ 21.79
